The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion

Aktan, Adem; Arslan, Bayram; BILIK, MEHMET ZIHNI; KILIÇ, RAİF; GÜZEL, TUNCAY

doi:10.30714/j-ebr.2021471924

The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion

Tuncay GÜZEL, (Sağlık Bilimleri Üniversitesi, Gazi Yaşargil Eğitim ve Araştırma Hastanesi, Kardiyoloji Anabilim Dalı, Diyarbakır, Türkiye)

Mehmet Zihni BİLİK, (Dicle Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Diyarbakır, Türkiye)

Bayram ARSLAN, (Dicle Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Diyarbakır, Türkiye)

Raif KILIÇ, (Dicle Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Diyarbakır, Türkiye)

Adem AKTAN (Dicle Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Diyarbakır, Türkiye)

Experimental Biomedical Research

13 0

Yıl: 2021 Cilt: 4 Sayı: 4 Sayfa Aralığı: 291 - 301 Metin Dili: İngilizce DOI: 10.30714/j-ebr.2021471924 İndeks Tarihi: 10-02-2022

The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion

Öz:

Aim: To demonstrate the correlation between coronary collateral circulation (CCC) and atherogenic plasmaindex (AIP), one of the factors associated with the formation of collateral vessels. Methods: Hospital records of patients with chronic total occlusion (100% stenosis) in at least one coronaryartery were evaluated. Triglycerides, HDL level, triglyceride/HDL ratio and atherogenic plasma index beforecoronary angiography were assessed for the 451 patients who met the study criteria.Results: Comparison of the two groups in terms of laboratory findings showed that triglyceride/HDL ratio(5.04±3.13 vs 3.56±2.12, p<0.001) and AIP (0.63±0.25 vs 0.48±0.25, p<0.001) were higher with statisticalsignificance in the weak collateral group. The ROC analysis revealed an association between weak collateralformation and atherogenic plasma index with 64.7% sensitivity and 66.2% specificity using a cut-off value of0.58 for AIP. Accordingly, low AIP was found to be an independent predictor of good collateral arteryformation.Conclusion: This study suggests that a high atherogenic plasma index may be an independent factor associatedwith poor collateral formation.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

[1]Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340(2):115- 26.
[2]Cohen MV. The functional value of coronary collaterals in myocardial ischemia and therapeutic approach to enhance collateral flow. Am Heart J. 1978;95(3):396- 404.
[3]Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001;49(3):554-60.
[4]Monette JS, Hutchins PM, Ronsein GE, et al. Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration. Circ Res. 2016;119(1):83-90.
[5]Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747-57.
[6]Topsakal R, Eryol NK, Abaci A, et al. The relation between chronic obstructive pulmonary disease and coronary collateral vessels. Angiology. 2005;56(6):651-56.
[7]Guelker JE, Bufe A, Blockhaus C, et al. The atherogenic index of plasma and its impact on recanalization of chronic total occlusion. Cardiol J. 2020;27(6):756-61.
[8]8. Teixeira BC, Lopes AL, Macedo RCO, et al. Inflammatory markers, endothelial function and cardiovascular risk. J Vasc Brasil. 2014;13(2):108–15.
[9]Tonet AC, Karnikowski M, Moraes CF, et al. Association between the-174G/C promoter polymorphism of the interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women. Braz J Med Biol Res. 2008;41(1):47-53.
[10]Tousoulis D, Plastiras A, Siasos G, et al. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. Atherosclerosis. 2014;232(1):10-16.
[11]Toikka JO, Ahotupa M, Viikari JS, et al. Constantly low HDLcholesterol concentration relates to endothelial dysfunction and increased in vivo LDLoxidation in healthy young men. Atherosclerosis. 1999;147(1):133-38.
[12]Abacı A, Oğuzhan A, Kahraman S et al. Effect of Diabetes Mellitus on Formation of Coronary Collateral Vessels. Circulation. 1999;99(17):2239-42.
[13]Elayda MA, Mather VS, Hall RJ, et al. Collateral circulation in coronary artery disease. Am J Cardiol. 1985;55(1):58-60.
[14]Levkau B, Hermann S, Theilmeier G, et al. High-density lipoprotein stimulates myocardial perfusion in vivo. Circulation. 2004;110(21):3355-59.
[15]Rossi F, Bertone C, Montanile F, et al. HDL cholesterol is a strong determinant of endothelial progenitor cells in hypercholesterolemic subjects. Microvasc Res. 2010;80(2):274-79.
[16]Spieker LE, Sudano I, Hurlimann D, et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation. 2002;105(12):1399-402.
[17]Higashi Y, Matsuoka H, Umei H, et al. Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells. Am J Physiol Endocrinol Metab. 2010;298(2):E202-9.
[18]Dobiás̆ová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34(7):583– 88.
[19]Khazaál MS. Atherogenic Index of Plasma (AIP) as a parameter in predicting cardiovascular risk in males compared to the conventional dyslipidemic indices (cholesterol ratios). Karbala J Med. 2013;6(1):1506–11.
[20]Niroumand S, Khajedaluee M, KhademRezaiyan M, et al. Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240.
[21]Wan K, Zhao J, Huang H, et al. The association between triglyceride/highdensity lipoprotein cholesterol ratio and allcause mortality in acute coronary syndrome after coronary revascularization. PLoS One. 2015;10(4):e0123521.
[22]Nam JS, Kim MK, Nam JY, et al. Association between atherogenic index of plasma and coronary artery calcification progression in Korean adults. Lipids Health Dis. 2020;19(1):157.
[23]Onat A, Can G, Kaya H, et al. Atherogenic index of plasma (log10 triglyceride/highdensity lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 2010;4(2):89-98.
[24]Liu T, Liu J, Wu Z, et all. Predictive value of the atherogenic index of plasma for chronic total occlusion before coronary angiography. Clin Cardiol. 2021;44(4):518- 25.

APA	GÜZEL T, BILIK M, Arslan B, KILIÇ R, Aktan A (2021). The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. , 291 - 301. 10.30714/j-ebr.2021471924
Chicago	GÜZEL TUNCAY,BILIK MEHMET ZIHNI,Arslan Bayram,KILIÇ RAİF,Aktan Adem The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. (2021): 291 - 301. 10.30714/j-ebr.2021471924
MLA	GÜZEL TUNCAY,BILIK MEHMET ZIHNI,Arslan Bayram,KILIÇ RAİF,Aktan Adem The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. , 2021, ss.291 - 301. 10.30714/j-ebr.2021471924
AMA	GÜZEL T,BILIK M,Arslan B,KILIÇ R,Aktan A The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. . 2021; 291 - 301. 10.30714/j-ebr.2021471924
Vancouver	GÜZEL T,BILIK M,Arslan B,KILIÇ R,Aktan A The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. . 2021; 291 - 301. 10.30714/j-ebr.2021471924
IEEE	GÜZEL T,BILIK M,Arslan B,KILIÇ R,Aktan A "The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion." , ss.291 - 301, 2021. 10.30714/j-ebr.2021471924
ISNAD	GÜZEL, TUNCAY vd. "The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion". (2021), 291-301. https://doi.org/10.30714/j-ebr.2021471924

APA	GÜZEL T, BILIK M, Arslan B, KILIÇ R, Aktan A (2021). The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. Experimental Biomedical Research, 4(4), 291 - 301. 10.30714/j-ebr.2021471924
Chicago	GÜZEL TUNCAY,BILIK MEHMET ZIHNI,Arslan Bayram,KILIÇ RAİF,Aktan Adem The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. Experimental Biomedical Research 4, no.4 (2021): 291 - 301. 10.30714/j-ebr.2021471924
MLA	GÜZEL TUNCAY,BILIK MEHMET ZIHNI,Arslan Bayram,KILIÇ RAİF,Aktan Adem The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. Experimental Biomedical Research, vol.4, no.4, 2021, ss.291 - 301. 10.30714/j-ebr.2021471924
AMA	GÜZEL T,BILIK M,Arslan B,KILIÇ R,Aktan A The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. Experimental Biomedical Research. 2021; 4(4): 291 - 301. 10.30714/j-ebr.2021471924
Vancouver	GÜZEL T,BILIK M,Arslan B,KILIÇ R,Aktan A The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion. Experimental Biomedical Research. 2021; 4(4): 291 - 301. 10.30714/j-ebr.2021471924
IEEE	GÜZEL T,BILIK M,Arslan B,KILIÇ R,Aktan A "The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion." Experimental Biomedical Research, 4, ss.291 - 301, 2021. 10.30714/j-ebr.2021471924
ISNAD	GÜZEL, TUNCAY vd. "The effect of atherogenic plasma index on collateral development in patients withchronic coronary total occlusion". Experimental Biomedical Research 4/4 (2021), 291-301. https://doi.org/10.30714/j-ebr.2021471924